Effective aminoglycoside antibiotic for multidrug-resistant bacteria
US11135234B2 · kind B2 · utility
0Cited by
11References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 22, 2020 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Jan 22, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.